» Articles » PMID: 16965865

Dose-volume Modeling of the Risk of Postoperative Pulmonary Complications Among Esophageal Cancer Patients Treated with Concurrent Chemoradiotherapy Followed by Surgery

Overview
Specialties Oncology
Radiology
Date 2006 Sep 13
PMID 16965865
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The aim of this study was to investigate the effect of radiation dose distribution in the lung on the risk of postoperative pulmonary complications among esophageal cancer patients.

Methods And Materials: We analyzed data from 110 patients with esophageal cancer treated with concurrent chemoradiotherapy followed by surgery at our institution from 1998 to 2003. The endpoint for analysis was postsurgical pneumonia or acute respiratory distress syndrome. Dose-volume histograms (DVHs) and dose-mass histograms (DMHs) for the whole lung were used to fit normal-tissue complication probability (NTCP) models, and the quality of fits were compared using bootstrap analysis.

Results: Normal-tissue complication probability modeling identified that the risk of postoperative pulmonary complications was most significantly associated with small absolute volumes of lung spared from doses > or = 5 Gy (VS5), that is, exposed to doses < 5 Gy. However, bootstrap analysis found no significant difference between the quality of this model and fits based on other dosimetric parameters, including mean lung dose, effective dose, and relative volume of lung receiving > or = 5 Gy, probably because of correlations among these factors. The choice of DVH vs. DMH or the use of fractionation correction did not significantly affect the results of the NTCP modeling. The parameter values estimated for the Lyman NTCP model were as follows (with 95% confidence intervals in parentheses): n = 1.85 (0.04, infinity), m = 0.55 (0.22, 1.02), and D50 = 17.5 Gy (9.4 Gy, 102 Gy).

Conclusions: In this cohort of esophageal cancer patients, several dosimetric parameters including mean lung dose, effective dose, and absolute volume of lung receiving < 5 Gy provided similar descriptions of the risk of postoperative pulmonary complications as a function of the radiation dose distribution in the lung.

Citing Articles

A Prospective Pilot Study of Pencil Beam Scanning Proton Radiation Therapy as a Component of Trimodality Therapy for Esophageal Cancer.

Hallemeier C, Merrell K, Neben-Wittich M, Jethwa K, Yoon H, Pitot H Adv Radiat Oncol. 2024; 9(8):101547.

PMID: 39081847 PMC: 11286993. DOI: 10.1016/j.adro.2024.101547.


Role of shrinkage in esophageal-gastric junction cancer.

Leongito M, Palaia R, Casaretti R, Tatangelo F, Foschini F, Di Mauro A Clin Case Rep. 2023; 11(6):e6982.

PMID: 37312927 PMC: 10258958. DOI: 10.1002/ccr3.6982.


Assessment of a diaphragm override strategy for robustly optimized proton therapy planning for esophageal cancer patients.

Visser S, Neh H, Oraboni Ribeiro C, Korevaar E, Meijers A, Poppe B Med Phys. 2021; 48(10):5674-5683.

PMID: 34289123 PMC: 9291176. DOI: 10.1002/mp.15114.


A Primer on Dose-Response Data Modeling in Radiation Therapy.

Moiseenko V, Marks L, Grimm J, Jackson A, Milano M, Hattangadi-Gluth J Int J Radiat Oncol Biol Phys. 2020; 110(1):11-20.

PMID: 33358230 PMC: 9339232. DOI: 10.1016/j.ijrobp.2020.11.020.


The use of tumour markers in oesophageal cancer to quantify setup errors and baseline shifts during treatment.

Thomas M, De Roover R, van der Merwe S, Lambrecht M, Defraene G, Haustermans K Clin Transl Radiat Oncol. 2020; 26:8-14.

PMID: 33251342 PMC: 7677672. DOI: 10.1016/j.ctro.2020.11.001.